Close Menu
    Facebook X (Twitter) Instagram
    Sunday, July 12
    Top Stories:
    • Volkswagen’s ID. Unyx 09: A Bold Redefinition We Need in the US!
    • Chinese startup targets 5nm chips without EUV by 2029
    • New Experimental Drug Reverses Severe Fatty Liver by Healing Gut
    Facebook X (Twitter) Instagram Pinterest Vimeo
    IO Tribune
    • Home
    • AI
    • Tech
      • Gadgets
      • Fashion Tech
    • Crypto
    • Smart Cities
      • IOT
    • Science
      • Space
      • Quantum
    • OPED
    IO Tribune
    Home » New Experimental Drug Reverses Severe Fatty Liver by Healing Gut
    Science

    New Experimental Drug Reverses Severe Fatty Liver by Healing Gut

    Lina Johnson MercilliBy Lina Johnson MercilliJuly 11, 2026No Comments2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Quick Takeaways

    1. Michigan researchers developed DT-109, a drug that reverses fatty liver disease in animals.
    2. DT-109 strengthens the gut barrier, reducing harmful microbes and inflammation in the liver.
    3. It decreased bacteria overgrowth and ammonia in the gut, improving liver health in animals.
    4. Potential broader uses include cardiovascular disease and digestive disorders like IBD.

    New Hope for Fatty Liver Disease

    Scientists have developed an experimental drug called DT-109 that shows promise in reversing severe fatty liver disease. In animal studies, this drug improved liver health by repairing the gut. Since fatty liver affects about 7% of people worldwide and can lead to serious health problems like cirrhosis and liver cancer, this discovery could be very important. The findings suggest that fixing gut health may be a new way to treat this tough condition, offering hope for millions. As research continues, scientists are optimistic about how this could help improve lives in the future.

    How the Gut and Liver Are Connected

    Researchers found that a specific gut bacterium, Clostridium perfringens, produces too much ammonia in the intestines. This high ammonia weakens the lining of the digestive tract, allowing harmful substances to enter the bloodstream. These substances then reach the liver, causing inflammation and damage. The new drug, DT-109, interrupts this harmful process by reducing bacteria levels and strengthening the gut barrier. This means fewer harmful products reach the liver, which can slow or stop disease progression and improve liver health.

    Broader Benefits and Future Possibilities

    Beyond fatty liver disease, DT-109 might help other health problems. Previous studies suggest it could prevent heart disease by reducing plaque buildup and artery hardening. It might also help with digestive disorders like inflammatory bowel disease. Future research will include testing the drug in humans to see if it is safe and effective. If successful, DT-109 could become a powerful tool for improving both liver and heart health, changing how we treat many metabolic and inflammatory conditions.

    Continue Your Tech Journey

    Explore the future of technology with our detailed insights on Artificial Intelligence.

    Access comprehensive resources on space and science by visiting NASA.

    Sci-BioV1

    Asia Biotech health Innovation Medical medicine Tech VT1
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleUnlocking the Perfect Coding Agent Interface
    Next Article Chinese startup targets 5nm chips without EUV by 2029
    Avatar photo
    Lina Johnson Mercilli
    • Website

    Lina Johnson Marcelli is the editor for IO Tribune, bringing over two decades of experience in journalism to her role. With a BA in Journalism, she is passionate about delivering impactful stories that resonate with readers. Known for her keen editorial vision and leadership, Lina is dedicated to fostering innovative storytelling across the publication. Outside of work, she enjoys exploring new media trends and mentoring aspiring journalists.

    Related Posts

    Tech

    Volkswagen’s ID. Unyx 09: A Bold Redefinition We Need in the US!

    July 11, 2026
    Tech

    Chinese startup targets 5nm chips without EUV by 2029

    July 11, 2026
    AI

    Unlocking the Perfect Coding Agent Interface

    July 11, 2026
    Add A Comment

    Comments are closed.

    Must Read

    Volkswagen’s ID. Unyx 09: A Bold Redefinition We Need in the US!

    July 11, 2026

    Chinese startup targets 5nm chips without EUV by 2029

    July 11, 2026

    New Experimental Drug Reverses Severe Fatty Liver by Healing Gut

    July 11, 2026

    Unlocking the Perfect Coding Agent Interface

    July 11, 2026

    Skyward Secrets: Stunning F-18 Views of Washington

    July 11, 2026
    Categories
    • AI
    • Crypto
    • Fashion Tech
    • Gadgets
    • IOT
    • OPED
    • Quantum
    • Science
    • Smart Cities
    • Space
    • Tech
    Most Popular

    Apple Explores Four Stylish Designs for Upcoming Smart Glasses to Compete with Meta Ray-Bans

    April 13, 2026

    Strategy Invests $450M to Acquire 4,048 BTC

    September 2, 2025

    Revolutionary Bacterial Kill Switch Could Transform Superbug Warfare

    February 28, 2026
    Our Picks

    Reimagining Tomorrow: Fixing Silicon Valley’s Vision of the Future

    November 1, 2025

    Chunks Causing RAG Failures!

    April 20, 2026

    Making Tech Disappear: Lego’s Smart Play Revolution

    January 9, 2026
    Categories
    • AI
    • Crypto
    • Fashion Tech
    • Gadgets
    • IOT
    • OPED
    • Quantum
    • Science
    • Smart Cities
    • Space
    • Tech
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
    • About Us
    • Contact us
    Copyright © 2025 Iotribune.comAll Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.